Higher doses of antipsychotics do not decrease odds of relapse

Antipsychotic doses above 5 mg/day risperidone equivalents do not appear to confer additional benefit for preventing relapse in patients with schizophrenia, but increase the risk of adverse effects, a new meta‐analysis reports. The findings suggest that antipsychotic doses of 2.5 mg/day risperidone ... View More